# ScoreItem: DHEA-S - Homens (70+ anos)

**ID:** `019bf31d-2ef0-749b-bd0e-c2f226330a10`
**FullName:** DHEA-S - Homens (70+ anos) (Exames - Laboratoriais)
**Unit:** Âµg/dL
**Gender:** male
**Age Min:** 70 anos
**Age Max:** 150 anos

**Preparation Metadata:**
- Quality Grade: **EXCELLENT**
- Total Chunks: 30 de 12 artigos
- Avg Similarity: 0.698

---

## Contexto

VocÃª Ã© um especialista em medicina funcional integrativa e estÃ¡ contribuindo com o **Escore Plenya** â€” um escore completo de anÃ¡lise de saÃºde que avalia todos os aspectos da saÃºde, performance e longevidade humana. Cada ScoreItem representa um parÃ¢metro clÃ­nico, laboratorial, genÃ©tico, comportamental ou histÃ³rico que compÃµe esse escore.

Seu papel Ã© gerar conteÃºdo clÃ­nico de alta qualidade para enriquecer cada parÃ¢metro do escore com relevÃ¢ncia clÃ­nica, orientaÃ§Ã£o ao paciente e conduta prÃ¡tica.

**Regras inegociÃ¡veis:**
- Use **apenas** o conhecimento mÃ©dico real consolidado e os dados presentes nos chunks cientÃ­ficos abaixo
- **NÃ£o alucine, nÃ£o invente** dados, estudos, estatÃ­sticas ou referÃªncias que nÃ£o estejam nos chunks ou no seu conhecimento mÃ©dico estabelecido
- Se um dado especÃ­fico nÃ£o constar nos chunks e nÃ£o for do seu conhecimento consolidado, **nÃ£o o inclua**
- Seja preciso: prefira omitir a inventar

## InstruÃ§Ã£o

Com base nos chunks cientÃ­ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-749b-bd0e-c2f226330a10`.**

```json
{
  "score_item_id": "019bf31d-2ef0-749b-bd0e-c2f226330a10",
  "clinical_relevance": "Texto tÃ©cnico para mÃ©dicos (1000-5000 chars): definiÃ§Ã£o fisiolÃ³gica precisa, valores de referÃªncia e interpretaÃ§Ã£o, fisiopatologia resumida, dados epidemiolÃ³gicos com nÃºmeros concretos, estratificaÃ§Ã£o de risco baseada em evidÃªncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que Ã© este parÃ¢metro sem jargÃµes, por que Ã© importante para a saÃºde, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta clÃ­nica em Markdown (1000-5000 chars): investigaÃ§Ã£o complementar necessÃ¡ria, critÃ©rios de encaminhamento a especialistas, intervenÃ§Ãµes baseadas em evidÃªncias. Use bullet points, seÃ§Ãµes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto clÃ­nico: 1-9 pts
- Alto impacto clÃ­nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- CritÃ©rios: gravidade/mortalidade (40%), prevalÃªncia (30%), intervencionabilidade (30%)

---

### Contexto CientÃ­fico

**ScoreItem:** DHEA-S - Homens (70+ anos) (Exames - Laboratoriais)
**Unidade:** Âµg/dL
**GÃªnero:** male
**Faixa EtÃ¡ria:** 70-150 anos

**30 chunks de 12 artigos (avg similarity: 0.698)**

### Chunk 1/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.745

composition with metabolism and disease. J Nutr Health Aging 2005;9:408â€“419
86. Berkman LF, Seeman TE, Albert M et al. High, usual and impaired functioning in
community-dwelling older men and women: Findings from the MacArthur Foundation
Research Network on Successful Aging. 
J Clin Epidemiol 1993;46:1129â€“1140
87. Morrison MF, Katz IR, Parmelee P et al. 
Dehydroepiandrosterone sulfate (DHEA-S) and
psychiatric and laboratory measures of frailty in a residential care population. Am J Geriatr
Psychiatry 1998;6:277â€“284
88. Abbasi A, Duthie EH, Sheldahl L et al. Association of dehydroepiandrosterone sulfate,
body composition, and physical fitness in independent communitydwelling older men and
women. J Am Geriatr Soc 1998;46:263â€“273
89. Clarke BL, Ebeling PR, Jones JD, Wahner HW, Oâ€™Fallon WM, Riggs BL, Fitzpatrick LA.
Predictors of bone mineraldensity in aging healthy men varies by skeletal site. Calcified Tiss
Int 2002;70:137â€“145
90.

---

### Chunk 2/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** other | **Similarity:** 0.738

men. Age Ageing 2009;38:401â€“406
70. Baulieu E, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate,
and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc Nat Acad Natl
Sci 2000;97:4279â€“84
71. Ohlsson C, Labrie F, Barrett-Connor E, Karlsson MK, Ljunggren O, et al. Low serum
levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in
elderly Swedish men. J Clin Endocrinol Metab 2010; 95: 4406â€“4414
72. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF (1999) DHEA and DHEA-S: a
review. 
J Clin Pharmacol 39: 327â€“348
73. Nair KS, Rizza RA, Oâ€™Brien P, et al. 
DHEA in elderly women and DHEA or testosterone
in elderly men. N Engl J Med 2006;355:1647â€“1659
74. William L. Baker, Shobha Karan, and Anne M. Kenny Effect of Dehydroepiandrosterone
on Muscle Strength and Physical Function in Older Adults: A Systematic Review. J Am
Geriatr Soc 2011;59:997â€“1002
75. Kritz-Silverstein D, von MÃ¼hlen D, Gail A.

---

### Chunk 3/30
**Article:** Dehydroepiandrosterone and its Sulfate Predict the 5-Year Risk of Coronary Heart Disease Events in Elderly Men (2014)
**Journal:** Journal of the American College of Cardiology
**Section:** abstract | **Similarity:** 0.731

Estudo prospectivo com 2.416 homens idosos (69-81 anos) seguidos por 5 anos demonstrou que nÃ­veis sÃ©ricos baixos de DHEA e DHEA-S predizem risco aumentado de eventos de doenÃ§a coronariana. Ambos DHEA e DHEA-S foram inversamente associados com risco ajustado por idade de evento coronariano (hazard ratios por SD de aumento: 0.82 e 0.86, respectivamente). Os nÃ­veis baixos de DHEA-S foram particularmente preditivos em homens mais jovens dentro da coorte, sugerindo que a mensuraÃ§Ã£o de DHEA-S pode ter valor prognÃ³stico cardiovascular em homens na quinta e sexta dÃ©cadas de vida.

---

### Chunk 4/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** discussion | **Similarity:** 0.723

n in the analysis. However, the potential inï¬‚uence of such metabolic factors on DHEA supplementation outcomes could introduce bias. Despite this, sensitivity analyses indicated that no single study disproportionately aï¬€ected the overall results, supporting the robustness of our conclusions.Our review did not account for these metabolic and comorbidity-related factors, which future research should control for or report in detail to minimize bias. Additionally, sensitivity analyses addressing these vari-ables would be valuable in future meta-analyses.Conclusionis meta-analysis found that DHEA supplementation at doses of 50 mg/day or higher signiï¬cantly increased testosterone levels, and in participants aged 60 years or older, signiï¬cantly elevated estradiol levels.

---

### Chunk 5/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.721

208
]. In humans studies, however, the results  are
rather inconsistent. In some studies, the lower levels of DHEA seen with aging have been
associated with impaired glucose tolerance, insulin resistance and diabetes [
212
-
215
], while
in another [
216
] exactly the opposite relation was shown as higher levels of DHEA were
13

associated with impaired glucose tolerance and diabetes mellitus in post-menopausal
women. The truth regarding DHEA/DHEAS and insulin resistance and its associated
conditions gets even more complicated considering conflicting results from interventional
studies with DHEA replacement. Thus, an ameliorating effect of long-term treatment with
DHEA on insulin resistance was described in a group of middle-aged hypo-adrenal women
treated with DHEA [
217
], but also in groups of elderly men [
97
] and postmenopausal women
[
97,217-220
] replaced with DHEA.

---

### Chunk 6/30
**Article:** Serum levels of dehydroepiandrosterone sulfate are associated with a lower risk of mobility-subtype frailty in older Japanese community-dwellers (2022)
**Journal:** Archives of Gerontology and Geriatrics
**Section:** abstract | **Similarity:** 0.720

Estudo prospectivo com 1.886 idosos da comunidade (60-91 anos) demonstrou que nÃ­veis sÃ©ricos mais elevados de DHEA-S foram associados a menor risco de fragilidade, especialmente fragilidade do subtipo mobilidade. A anÃ¡lise de medidas repetidas confirmou que a manutenÃ§Ã£o de nÃ­veis adequados de DHEA-S ao longo do tempo estÃ¡ inversamente relacionada ao desenvolvimento de fragilidade em idosos vivendo na comunidade, sugerindo papel protetor deste hormÃ´nio na preservaÃ§Ã£o da funÃ§Ã£o fÃ­sica.

---

### Chunk 7/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** other | **Similarity:** 0.720

-I and testosterone in
healthy active elderly people. Eur J Appl Physiol 2000;82:83â€“90
67. Ravaglia G, Forti P, Maioli F, Boschi F, Cicognani A, Bernardi M, Pratelli L, Pizzoferrato
A, Porcu S, Gasbarrini G. Determinants of functional status in healthy Italian nonagenarians
and centenarians: A comprehensive functional assessment by the instruments of geriatric
practice. J Am Geriatr Soc 1997;45:1196â€“1202
68. Leng SX, Cappola AR, Anderson RE et al. Serum levels of insulin-like growth factor-I
(IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum
interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 2004;16:153â€“157
69. Voznesensky M, Walsh S, Dauser D et al. The association between
dehydroepiandosterone and frailty in older men and women. Age Ageing 2009;38:401â€“406
70. Baulieu E, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate,
and aging: contribution of the DHEAge study to a sociobiomedical issue.

---

### Chunk 8/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** discussion | **Similarity:** 0.711

ffect of Dehydroepiandrosterone
on Muscle Strength and Physical Function in Older Adults: A Systematic Review. J Am
Geriatr Soc 2011;59:997â€“1002
75. Kritz-Silverstein D, von MÃ¼hlen D, Gail A. Laughlin GA, Bettencourt R. Effects of
dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA
and well-ness (DAWN) trial. J Am Geriat Soc 2008;56:1292â€“8
76. Panjari M, Bell RJ, Jane F, et al..A randomized trial of oral DHEA treatment for sexual
function, well-being, and menopausal symptoms in postmenopausal women with low libido. J
Sex Med 2009; 6: 2579â€“2590
77. Alkatib AA, Cosma M, Elamin MB, et al. A systematic review and metaanalysis of
randomized placebo-controlled trials of DHEA treatment effects on quality of life in women
with adrenal insufficiency.
J Clin Endocrinol Metab 2009;94:3676â€“81
78. Labrie F, Archer D, Bouchard C, et al.

---

### Chunk 9/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.709

Stanczyk FZ, Bairey Merz CN. DHEA-S levels and
cardiovascular disease mortality in postmenopausal women: Results from the National
Institutes of Healthâ€“National Heart, Lung, and Blood Institute (NHLBI)-sponsored Womenâ€™s
Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab 2010;95:4985â€“4992
204. Christiansen JJ, Andersen NH, SÃ¸rensen KE, Pedersen EM, Bennett P, Andersen M,
Christiansen JS, JÃ¸rgensen JO, Gravholt CH. Dehydroepiandrosterone substitution in
female adrenal failure: no impact on endothelial function and cardiovascular parameters
despite normalization of androgen status. Clin Endocrinol 2007;66:426â€“433
205. Panjari M, Bell RJ, Jane F, Adams J, Morrow C, Davis SR. The safety of 52 weeks of
oral DHEA therapy for postmenopausal women. Maturitas 2009;63:240â€“245
206. Cleary MP, Zisk JF. Anti-obesity effect of two different levels of
dehydroepiandrosterone in lean and obese middle-aged female Zucker rats. Int J Obes
1986;10:193â€“204
207.

---

### Chunk 10/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.706

man  HA,  Johannes  CB,  Araujo  AB,  Mohr  BA,  Longcope  C,  McKinlay  JB.
Low dehydroepiandrosterone  and  ischemic  heart  disease  in  middle-aged  men:
prospective  results  from  the  Massachusetts  Male  Aging  Study.  Am  J  Epidemiol
2001;153:79â€“89
246. Trivedi  DP,  Khaw  KT.  Dehydroepiandrosterone  sulfate  and  mortality  in elderly
men  and  women.  J  Clin  Endocrinol  Metab  2001;86:4171â€“7
247. Hak  AE,  Witteman  JC,  de  Jong  FH,  Geerlings  MI,  Hofman  A,  Pols  HA.  Low
levels of  endogenous  androgens  increase  the  risk  of  atherosclerosis  in  elderly  men:
the  Rotterdam  study.  J  Clin  Endocrinol  Metab  2002;87:3632â€“9
248. Herrington  DM,  Gordon  GB,  Achuff  SC,  Trejo  JF,  Weisman  HF,  Kwiterovich  Jr
PO,  et  al.  Plasma  dehydroepiandrosterone  and  dehydroepiandrosterone  sulfate  in
patients  undergoing  diagnostic  coronary  angiography.  J  Am  Coll Cardiol  1990;16:862â€“
70
249.

---

### Chunk 11/30
**Article:** A Review of Age-Related Dehydroepiandrosterone Decline and Its Association with Well-Known Geriatric Syndromes: Is Treatment Beneficial? (2013)
**Journal:** Rejuvenation Research
**Section:** abstract | **Similarity:** 0.705

RevisÃ£o abrangente sobre o declÃ­nio de DHEA relacionado Ã  idade e associaÃ§Ãµes com sÃ­ndromes geriÃ¡tricas. NÃ­veis de DHEA variam entre 1,33-7,78 ng/mL entre 18-40 anos, declinando para 10-20% desses valores aos 70-80 anos. AssociaÃ§Ãµes primÃ¡rias incluem deterioraÃ§Ã£o musculoesquelÃ©tica (forÃ§a muscular, densidade Ã³ssea), declÃ­nio cognitivo, transtornos de humor e risco cardiovascular.

---

### Chunk 12/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** other | **Similarity:** 0.701

sterone (DHEA) and its active metabolite DHEA sulfate (DHEAS), are
steroid hormones synthesized and excreted primarily by the 
zona reticularis
 of the adrenal
cortex in response to adrenocorticotropic hormone (ACTH). They exert weak androgenic
effects and are therefore considered precursor hormones that need to be transformed to
potent androgens or estrogens to exert their effects. The potential clinical roles of
DHEA/DHEAS have been studied extensively, as previous epidemiologic and prospective
studies associated the age-related decrease of DHEA/DHEAS levels with higher prevalence
of degenerative disorders and increased frailty and mortality from all causes in the elderly,
attributing to adrenal androgens anti-ageing properties. But do they really suggest that they
are hormones related to longevity or just another pointless alchemy against ageing?

---

### Chunk 13/30
**Article:** Dehydroepiandrosterone Supplementation in Elderly Men: A Meta-Analysis Study of Placebo-Controlled Trials (2013)
**Journal:** The Journal of Clinical Endocrinology & Metabolism
**Section:** abstract | **Similarity:** 0.700

Meta-anÃ¡lise de ensaios clÃ­nicos randomizados controlados por placebo avaliando suplementaÃ§Ã£o de DHEA em homens idosos. Os resultados nÃ£o demonstraram efeito da suplementaÃ§Ã£o de DHEA em comparaÃ§Ã£o com placebo para diversos parÃ¢metros clÃ­nicos incluindo metabolismo lipÃ­dico e glicÃªmico, saÃºde Ã³ssea, funÃ§Ã£o sexual e qualidade de vida. A suplementaÃ§Ã£o foi associada Ã  reduÃ§Ã£o da massa gorda, porÃ©m este efeito depende estritamente da conversÃ£o do DHEA em metabÃ³litos bioativos como andrÃ³genos ou estrogÃªnios.

---

### Chunk 14/30
**Article:** Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men (2010)
**Journal:** Journal of Clinical Endocrinology and Metabolism
**Section:** abstract | **Similarity:** 0.698

Estudo prospectivo com 2.644 homens suecos idosos (69-81 anos) demonstrou que nÃ­veis sÃ©ricos baixos de DHEA-S predizem mortalidade por todas as causas (HR 1.54), doenÃ§a cardiovascular (HR 1.61) e doenÃ§a cardÃ­aca isquÃªmica (HR 1.67). Notavelmente, a prediÃ§Ã£o de mortalidade por DHEA-S baixo foi mais pronunciada em homens mais jovens (HR ajustado por idade para morte cardiovascular 2.64) comparado a homens mais velhos (HR 1.30). Estes achados sugerem que a mensuraÃ§Ã£o de DHEA-S em homens na quinta dÃ©cada pode identificar indivÃ­duos com risco cardiovascular aumentado.

---

### Chunk 15/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** results | **Similarity:** 0.695

was further supported by the results of EggerÂ’s regression test.Discussionis meta-analysis of randomized controlled trials (RCTs) evaluated the eï¬€ects of dehydroepiandrosterone (DHEA) supplementation on testosterone and estradiol levels in postmenopausal women. Our analysis of 21 RCTs revealed that DHEA supplementation signiï¬cantly increased both testosterone and estradiol concentrations, although substantial heterogeneity was observed across the included trials.Our ï¬ndings indicate that DHEA is particularly eï¬€ec-tive in elevating testosterone levels when administered at dosages  50 mg/day. Additionally, a marked increase in estradiol levels was noted among participants aged  60 years receiving the same dosage. ese ï¬ndings 
Fig. 2 Forest plot of the randomized controlled trials investigating the eï¬€ect of dehydroepiandrosterone (DHEA) supplementation on serum estradiol concentrations

Page 9 of 13
Heetal. Diabetology & Metabolic Syndrome          (2025) 17:258 
Fig.

---

### Chunk 16/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.692

andgaitspeed.Furtherresultsshowedthatpostmeno-pausalwomenwithsarcopeniaweremorelikelytohavehigherDHEAlevels.However,T2andE2werenotre-latedtomusclemass,gripstrengthorgaitspeed.TheseresultssuggestedthatthecirculatingsexhormonesDHEAwasabetterbiomarkerthanT2andE2formusclestrengthandgaitspeed,whichlikelyoccurredbecauseDHEAisaprecursorforsexsteroids.Threerea-sonsmaysupportthishypothesis.First,DHEAdoesnotbindtosexhormone-bindingglobulin(SHBG),whichsuggeststhatDHEAhasfreeaccesstotargetorganscomparedtoSHBG-boundE2andT2[24].Second,DHEAisanandrogenprehormoneproducedinthezonareticularisofthefemaleadrenalglandandovarianthecacells,anditactsasanupstreamprecursorofT2andE2inpostmenopausalwomen[25].DHEAinpostmeno-pausalwomenbecomesthepredominantsexhormoneinsteadofE2[26].CirculatingDHEAprovidessubstratesthatarerequiredforconversionintopotentandrogensandestrogensinperipheraltissues.SkeletalmusclesarecapableofsynthesizingandrogensandestrogensfromDHEA[27].Therefore,TandE2levelsinserumdonotrepresenttheconcen

---

### Chunk 17/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** other | **Similarity:** 0.689

ement
in healthy men with age-related decline of DHEA-S: Effects on fat distribution, insulin
sensitivity and lipid metabolism. Aging Male 2003; 6:151â€“156
27

108. Callies F, Fassnacht M, van Vlijmen JC, Koehler I, Huebler D, Seibel MJ, Arlt W, Allolio
B. Dehydroepiandrosterone replacement in women with adrenal insufficiency: Effects on
body composition, serum leptin, bone turnover, and exercise capacity. J Clin Endocrinol
Metab 2001;86:1968â€“ 1972
109. Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, Allen S, Krause G.
Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab
1999;84:1527â€“1533
110. Percheron G, Hogrel JY, Denot-Ledunois S, Fayet G, Forette F, Baulieu EE, Fardeau
M, Marini JF. Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-
year-old individuals on muscle function and cross-sectional area: A double-blind placebo-
controlled trial. Arch Int Med 2003;163:720â€“727
111.

---

### Chunk 18/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** discussion | **Similarity:** 0.686

HEA) supplementation on serum levels of insulin-like growth factor 1 (IGF-1): a dose-response meta-analysis of randomized controlled trials. Exp Gerontol. 2020;136:110949. 4. Mohamad N-V, Razali N-SC, Shamsuddin N-AM. Dehydroepiandros-terone and bone health: mechanisms and insights. Biomedicines. 2024;12(12):2780. 5. Mueller JW, Gilligan LC, Idkowiak J, Arlt W, Foster PA. The regula-tion of steroid action by sulfation and desulfation. Endocr Rev. 2015;36(5):526Â–63. 6. Tang J, Chen L-R, Chen K-H. The utilization of dehydroepiandrosterone as a sexual hormone precursor in premenopausal and postmenopausal women: an overview. Pharmaceuticals. 2021;15(1):46. 7. Yang N-C, Jeng K-CG, Ho W-M, Chou S-J, Hu M-L. DHEA inhibits cell growth and induces apoptosis in BV-2 cells and the eï¬€ects are inversely associated with glucose concentration in the medium. J Steroid Biochem Mol Biol. 2000;75(2Â–3):159Â–66. 8. De Menezes KJ, Peixoto C, Nardi AE, Carta MG, Machado S, Veras AB.

---

### Chunk 19/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** other | **Similarity:** 0.686

:4279â€“
84
21

18. Mazat  L,  Lafont  S,  Berr  C,  Debuire  B,  Tessier  JF,  Dartigues  JF,  et  al.
Prospective measurements  of  dehydroepiandrosterone  sulfate  in  a  cohort  of  elderly
subjects:  relationship  to  gender,  subjective  health,  smoking  habits,  and 10-year
mortality.  Proc  Natl  Acad  Sci  U  S  A  2001;98:8145â€“50
19. Heaney JL, Phillips AC, Carroll D. Ageing, physical function, and the diurnal rhythms of
cortisol and dehydroepiandrosterone.Psychoneuroendocrinology. 2012;37(3):341-9
20. Laughlin, G. A. and Barrett-Connor, E. Sexual dimorphism in the influence of advanced
aging on adrenal hormone levels: the Rancho Bernardo Study. J Clin Endocrinol Metab
2000;85:3561-3568
21. Baulieu  EE.  Androgens  and  aging  men.  Mol  Cell  Endocrinol  2002;198:41â€“9
22. 
Parker, C.R. Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in
the human adrenal during development and aging. Steriods 1999;64, 640â€”647
23. Yen, S.S.C., Laughlin, G.A.

---

### Chunk 20/30
**Article:** Lower testosterone levels are associated with higher risk of death in men (2026)
**Journal:** Revista nÃ£o identificada
**Section:** results | **Similarity:** 0.686

vels of testosterone. Further research is needed to determine if and when low testosterone levels are a cause or consequence of health problems that elevate oneÂ’s mortality risk.Conrmation that low testosterone is more of a symptom than a cause of chronic health problems during aging would challenge the marketing of testosterone supplementation as a panacea for menÂ’s health issues, ranging from low sexual function, to unideal body composition, to general aging []. Such ndings would also raise questions about the utility of testosterone-re-placement therapy as a means of reducing mortality risk in aged men. Studies on the impact of testosterone-replacement therapy on male mortality, to date, have yielded mixed results [Â–]. 
Figure . Hazard ratios by testosterone level for heart diseases, cerebrovascular diseases and malignant neoplasms.

---

### Chunk 21/30
**Article:** MFI - ReposiÃ§Ã£o Hormonal - AULA 01 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.684

80 anos com testosterona de 500-600, sugerindo que seus nÃ­veis de pico na juventude poderiam ter sido muito mais altos (ex: 1.500).
*   **DeclÃ­nio Hormonal Feminino e DHEA**
    - Mulheres tambÃ©m experimentam um declÃ­nio na testosterona, que Ã© produzida pelos ovÃ¡rios e adrenais. A queda pode ser menos linear que nos homens, pois a produÃ§Ã£o adrenal pode ser preservada.
    - O DHEA (deidroepiandrosterona), um prÃ³-hormÃ´nio precursor, diminui nitidamente com a idade, indicando um "desgaste" da glÃ¢ndula adrenal.
    - A prescriÃ§Ã£o de DHEA (prasterona no Brasil) Ã© feita em comprimidos (forma mais estudada) ou creme (forma mais fisiolÃ³gica). Doses para mulheres sÃ£o menores (10-15mg) para evitar conversÃµes indesejadas. Para homens, sua funÃ§Ã£o como estimulador de outros hormÃ´nios Ã© menos estabelecida.
### 4.

---

### Chunk 22/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** discussion | **Similarity:** 0.683

o-
DHEA ratios among working individuals. Yonsei Med J 2010; 51: 212â€“218
175. Lennartsson A-K, Theorell T, Rockwood AL, Kushnir MM, Jonsdottir IH Perceived
Stress at Work Is Associated with Lower Levels of DHEA-S. PloS ONE 2013;  8: e72460
176. Jorm AF, Jolley D. The incidence of dementia: a meta-analysis.Neurology 1998;
51:728-33
177. Lu SF, Mo Q, Hu S, Garippa C, Simon NG. Dehydroepiandrosterone upregulates
neural androgen receptor level and transcriptional activity. J Neurobiol 2003;57:163â€“71
178. Suzuki M, Wright LS, Marwah P, Lardy HA, Svendsen CN. Mitotic and neurogenic
effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from
the fetal cortex. Proc Natl Acad Sci USA 2004;101:3202â€“3207
179. Lang PO, Lapenna A, Pitts D, Aspinall R. Immunological pathogenesis of main age-
related diseases and frailty: Role of immunosenescence. Eur Ger Med 2010;1:112â€“121
180. 
Davis SR
,
 
Shah SM
,
 
McKenzie DP
,
 
Kulkarni J
,
 
Davison SL
,
 
Bell RJ
.

---

### Chunk 23/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** other | **Similarity:** 0.681

verted into its sulfated form, DHEA sulfate (DHEA-S), which circulates at much higher concentrations and can be further metabolized into active sex hormones as needed [5].DHEA levels decline signiï¬cantly with age, decreasing by approximately 70% between the ages of 20 and 60, pri-marily due to reduced adrenal production. DHEA sup-plementation has been explored as an adjunct therapy for postmenopausal women, alongside hormone replace-ment therapy (HRT), and has demonstrated potential beneï¬ts in improving metabolic and endocrine function, as well as sexual health [6]. DHEA exerts androgenic, estrogenic, and steroidal eï¬€ects and has been associated with various biological functions, including antioxidant properties, neuroprotection, and anticancer activity [7].

---

### Chunk 24/30
**Article:** Lower testosterone levels are associated with higher risk of death in men (2026)
**Journal:** Revista nÃ£o identificada
**Section:** results | **Similarity:** 0.681

ere analyzed using data from multiple samples of the cross-sectional National Health and Nutrition Examination Survey (n = ). Target outcomes included known deaths from heart disease, malignant neoplasms, chronic lower respiratory diseases, cerebrovascular diseases, AlzheimerÂ’s disease, diabetes mellitus, inuenza and pneumonia, kidney diseases, and accidents or unintentional injuries.Results:  Results of discrete-time hazard models revealed that lower levels of testosterone were related to higher mortality for the majority of disease categories in either an age-dependent or age-independent fashion. Analysis of all-cause mortalityÂ—which included deaths from any known diseaseÂ—also revealed greater general risk for those with lower testosterone levels. For most disease categories, the hazard associated with low testosterone was especially evident at older ages when mortality from that particular ailment was already elevated.

---

### Chunk 25/30
**Article:** Lower testosterone levels are associated with higher risk of death in men (2026)
**Journal:** Revista nÃ£o identificada
**Section:** results | **Similarity:** 0.681

-one levels do appear to be linked to male health [, ], and changing levels during the lifespan could reect alterations in trade-o investments with resultant altered physiological func-tioning that may contribute to mortality. Previous studies exam-ining links between testosterone levels and menÂ’s mortality risk have yielded mixed results: many nd increased risk from certain causes at low testosterone levels, some nd decreased risk, and still, others nd no signicant relationship between testosterone and mortality [Â–]. Heterogeneity in such research results is likely attributable to dierences in sample characteristics (e.g. mean age), but may also reect bidirectionality in relationships between androgens and health.Testosterone levels decreaseÂ—often dramaticallyÂ—in response to many infectious illnesses (e.g.

---

### Chunk 26/30
**Article:** Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Womenâ€”A J-shaped Relationship (2023)
**Journal:** The Journal of Clinical Endocrinology & Metabolism
**Section:** abstract | **Similarity:** 0.680

Estudo prospectivo com 7.370 participantes (idade mÃ©dia 55 anos homens, 52,4 anos mulheres) demonstrando relaÃ§Ã£o em J entre DHEA-S e mortalidade. NÃ­veis muito baixos e muito altos de DHEA-S foram associados com maior mortalidade, sugerindo que existe uma faixa Ã³tima de DHEA-S para longevidade em indivÃ­duos de meia-idade e idosos.

---

### Chunk 27/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** discussion | **Similarity:** 0.679

randomized clinical trials. Exp Gerontol. 2020;141: 111110. 41. Zhu Y, Qiu L, Jiang F, GÄƒman M-A, Abudoraehem OS, Okunade KS, et al. The eï¬€ect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: a dose-response and meta-analysis of randomized clinical trials. Steroids. 2021;173:108889. 42. Jamka K, Adamczuk P, Skowronska A, Bojar I, Raszewski G. Assess-ment of the eï¬€ect of estradiol on biochemical bone turnover markers among postmenopausal women. Ann Agric Environ Med. 2021;28(2):78Â–96. 43. Clark BJ, Prough RA, Klinge CM. Mechanisms of action of dehydroepi-androsterone. Vitam Horm. 2018;108:29Â–73. 44. Brzozowska M, LewiÅ„ski A. Changes of androgens levels in meno-pausal women. Menopause Review/PrzeglÄ…d Menopauzalny. 2020;19(4):151Â–4. 45. Nair KS, Rizza RA, OÂ’Brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355(16):1647Â–59. 46. Villareal DT, Holloszy JO.

---

### Chunk 28/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** discussion | **Similarity:** 0.676

y [
206
-
208
]. In
humans, two sets of longitudinal analyses of studies with women in menopausal transition
showed that elevated DHEAS level is negatively related to BMI [
30
,
31
]. On the other hand,
baseline analyses by Santoro et al [
209
] did not find much association between DHEAS and
BMI, waist-hip ratio, or waist. Similarly, a 2-year, placebo-controlled, randomized, double-
blind study involving elderly men and women with low levels of DHEAS, showed no
significant effect of DHEA replacement (75 mg per day, 
per os
) on body composition
measurements [
73
].
  Interestingly, a, recent meta-analysis of intervention studies showed
that DHEA supplementation in elderly men can induce only a small  positive effect on body
composition which is strictly dependent on DHEA conversion into its bioactive metabolites
such as androgens or estrogens [
210].

---

### Chunk 29/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** introduction | **Similarity:** 0.675

lasma levels of adrenal androgens and CVD. Most have shown that low
plasma levels of  DHEA/DHEA-S  were clearly associated with increased incidence of
atherosclerotic vascular diseases [239-243] and cardiovascular morbidity [241,244-250],
independently from classic cardiovascular risk factors, as well as with increased CVD-related
mortality in elderly men [18,71,251-253] but not in postmenopausal women [18,246,251-
253], unless they had pre-existing coronary disease [203]. 
The plasma levels of DHEA were also inversely associated with the progression [254] and
prognosis of heart failure [255], at least in men. The exact pathophysiologic background is
still more or less unclear. Some preliminary data in patients with type 2 diabetes mellitus
suggest that the adrenal androgens may increase the generation of activated protein C, an
important anticoagulant protein that protects from acute 
coronary
 events [235].

---

### Chunk 30/30
**Article:** Ritmo Circadiano Eixo HPA - Parte VI (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.673

or sobrevivÃªncia; em mulheres, nÃ£o houve diferenÃ§a significativa. A baixa variabilidade de estresse sugere que a capacidade intrÃ­nseca de produzir DHEA pode ser fator protetor.
- **Estudo 2 (DoenÃ§as Cardiovasculares):** Em idosos, baixos nÃ­veis de DHEA foram associados a aumento na incidÃªncia de doenÃ§as cardiovasculares.
- **Estudo 3 (Sul da FranÃ§a):** Comparou tabagismo com baixos nÃ­veis de sulfato de DHEA como preditores de mortalidade. Risco relativo semelhante (2,0 para fumantes vs. 1,9 para baixo DHEA), indicando baixo DHEA como fator de risco quase tÃ£o significativo quanto fumar.
- A relaÃ§Ã£o Cortisol/DHEA Ã© usada em alguns estudos, mas clinicamente Ã© mais Ãºtil entender que baixo DHEA sinaliza estresse crÃ´nico.
> **SugestÃµes da IA**
> A anÃ¡lise dos estudos foi muito bem conduzida ao contextualizar as populaÃ§Ãµes. VocÃª evitou conclusÃµes causais diretas, como "suplementar DHEA para todos".

---

